Exelixis Inc (EXEL)
34.03
+0.21
(+0.62%)
USD |
NASDAQ |
Dec 26, 16:00
34.02
-0.01
(-0.03%)
After-Hours: 20:00
Exelixis Free Cash Flow: 404.94M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co Inc | 14.84B |
| ADMA Biologics Inc | 78.82M |
| Alnylam Pharmaceuticals Inc | 16.06M |
| Pfizer Inc | 8.227B |
| Sarepta Therapeutics Inc | -480.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 271.34M |
| Cash from Investing (Quarterly) | -217.15M |
| Cash from Financing (Quarterly) | 5.696M |
| Free Cash Flow Per Share (Quarterly) | 0.8994 |
| Free Cash Flow to Equity (Quarterly) | 262.14M |
| Free Cash Flow to Firm (Quarterly) | 262.14M |
| Free Cash Flow Yield | 3.95% |